| Surgery in haemophilic patients with inhibitor: 20 years of experience M Quintana‐Molina, F Martinez‐Bahamonde, E Gonzalez‐Garcia, ... Haemophilia 10, 30-40, 2004 | 93 | 2004 |
| Procoagulant profile in patients with immune thrombocytopenia MT Álvarez‐Román, I Fernández‐Bello, V Jiménez‐Yuste, ... British journal of haematology 175 (5), 925-934, 2016 | 59 | 2016 |
| Experience of tailoring prophylaxis using factor VIII pharmacokinetic parameters estimated with myPKFiT® in patients with severe haemophilia A without inhibitors. MT Álvarez-Román, I Fernandez-Bello, H De La Corte-Rodríguez, ... Haemophilia: the official journal of the World Federation of Hemophilia 23 …, 2017 | 52 | 2017 |
| Endothelial dysfunction and altered coagulation as mediators of thromboembolism in Behçet disease NV Butta, I Fernández-Bello, FJ Lopez-Longo, V Jiménez-Yuste Seminars in thrombosis and hemostasis, 621-628, 2015 | 47 | 2015 |
| Platelet apoptosis and PAI-1 are involved in the pro-coagulant state of immune thrombocytopaenia patients treated with thrombopoietin receptor agonists RJ Sanz, EM Manzano, IF Bello, MTÁ Román, MM Salces, MIR Pollmar, ... Thrombosis and Haemostasis 119 (04), 645-659, 2019 | 35 | 2019 |
| Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients IF Bello, MT Álvarez, FJ López-Longo, EG Arias-Salgado, M Martín, ... Thrombosis and haemostasis 107 (01), 88-98, 2012 | 35 | 2012 |
| Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia MTÁ Román, IF Bello, EG Arias-Salgado, MIR Pollmar, VJ Yuste, ... Thrombosis and haemostasis 112 (07), 65-72, 2014 | 34 | 2014 |
| Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity I Fernández-Bello, FJ López-Longo, EG Arias-Salgado, V Jiménez-Yuste, ... Orphanet journal of rare diseases 8, 1-9, 2013 | 32 | 2013 |
| Fanhdi®, efficacy and safety in von Willebrand’s disease: prospective international study results IF Bello, VJ Yuste, MQ Molina, FH Navarro Haemophilia 13, 25-32, 2007 | 32 | 2007 |
| Procoagulant state of sleep apnea depends on systemic inflammation and endothelial damage I Fernández-Bello, EM Manzano, FG Río, RJ Sanz, C Cubillos-Zapata, ... Archivos de Bronconeumologia 58 (2), 117-124, 2022 | 30 | 2022 |
| Platelet and immune characteristics of immune thrombocytopaenia patients non‐responsive to therapy reveal severe immune dysregulation E Monzón Manzano, MT Álvarez Román, R Justo Sanz, I Fernández Bello, ... British Journal of Haematology 189 (5), 943-953, 2020 | 29 | 2020 |
| The pharmacokinetics and pharmacodynamics of single‐dose and multiple‐dose recombinant activated factor VII in patients with haemophilia A or B I Fernández‐Bello, C Stenmo, N Butta, V Lind, M Ezban, V Jiménez‐Yuste Haemophilia 23 (6), 868-876, 2017 | 17 | 2017 |
| Platelet apoptosis and agonist-mediated activation in myelodysplastic syndromes M Martín, R de Paz, V Jiménez-Yuste, IF Bello, EGA Salgado, MT Álvarez, ... Thrombosis and haemostasis 109 (05), 909-919, 2013 | 16 | 2013 |
| Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia MT Álvarez-Román, MIR Pollmar, JI Bernardino, ML Lozano, ... Aids 30 (7), 1141-1142, 2016 | 10 | 2016 |
| Insights into the procoagulant profile of patients with systemic lupus erythematosus without antiphospholipid antibodies E Monzón Manzano, I Fernández-Bello, R Justo Sanz, ... Journal of Clinical Medicine 9 (10), 3297, 2020 | 9 | 2020 |
| Clinical trials and Haemophilia during the COVID‐19 pandemic: Madrid's experience MT Álvarez‐Román, S García‐Barcenilla, T Cebanu, E González‐Zorrilla, ... Haemophilia 26 (5), e247, 2020 | 8 | 2020 |
| Effect of thrombopoietin-receptor agonists on a proliferation-inducing ligand (APRIL) plasma levels in patients with immune thrombocytopaenia MTÁ Román, IF Bello, EG Arias-Salgado, R de Paz, VJ Yuste, MM Salces, ... British Journal of Clinical Pharmacology 78 (3), 674, 2014 | 6 | 2014 |
| Procoagulant status in patients with immune thrombocytopenia IF Bello, MÁ Román, EGA Salgado, MM Salces, M Canales, VJ Yuste, ... Blood 122 (21), 3528, 2013 | 3 | 2013 |
| Real life experience in clinical practice with recombinant coagulation FVIII-Fc fusion protein TÁ Roman, EM Manzano, I Fernandez-Bello, M Martin, MIR Pollmar, ... Blood 134, 4929, 2019 | 2 | 2019 |
| Thromboelastometry may be useful to guide treatment for breakthrough and perioperative bleeds of patients on prophylaxis with emicizumab I Fernandez-Bello, M Alvarez-Roman, M Martin-Salces, I Rivas-Pollmar, ... Haemophilia 25, 106-107, 2019 | 2 | 2019 |
